| 01st week of 2021 patent applcation highlights part 8 |
| Patent application number | Title | Published |
|---|
| 20210000704 | COSMETIC COMPOSITIONS USING TITANIUM DIOXIDE PARTICLES FOR IR PROTECTION | 2021-01-07 |
| 20210000705 | ORGANIC-INORGANIC COMPOSITE PARTICLES, MANUFACTURING METHOD THEREFOR, AND COSMETIC | 2021-01-07 |
| 20210000706 | WATER IN OIL TYPE COSMETIC COMPOSITION FOR PREVENTING SYNERESIS | 2021-01-07 |
| 20210000707 | NANOEMULSIONS WITH COLOR STABILIZED ACTIVES | 2021-01-07 |
| 20210000708 | MAGNETIC EYE LINE, LIQUID EYELINER AND GEL EYELINER, AND MAGNETIC ADSORPTION-TYPE FALSE EYELASH CORRESPONDING THERETO AND WEARING METHOD THEREFOR | 2021-01-07 |
| 20210000709 | Oral Care Compositions and Methods | 2021-01-07 |
| 20210000710 | PHOSPHATE CROSSLINKED STARCH NANOPARTICLE AND DENTAL TREATMENTS | 2021-01-07 |
| 20210000711 | USE OF KAOLIN AS AN OPACIFIER | 2021-01-07 |
| 20210000712 | SKIN COMPOSITION BOOSTER OIL | 2021-01-07 |
| 20210000713 | Cleansing Bars | 2021-01-07 |
| 20210000714 | ALCOHOL-BASED HAND CONDITIONERS FOR REPEATED USE | 2021-01-07 |
| 20210000715 | COSMETIC COMPOSITIONS CONTAINING QUINONES AND THEIR TOPICAL USE ON SKIN AND HAIR | 2021-01-07 |
| 20210000716 | CLEANER COMPOSITION | 2021-01-07 |
| 20210000717 | MICELLAR EXTENDED RELEASE NANOSTRUCTURES | 2021-01-07 |
| 20210000718 | LIQUID COMPOSITIONS FOR HAIR REMOVAL DEVICES COMPRISING METATHESIZED UNSATURATED POLYOL ESTERS | 2021-01-07 |
| 20210000719 | NON-IONIC DEEP EUTECTIC MIXTURES FOR USE AS SOLVENTS AND DISPERSANTS | 2021-01-07 |
| 20210000720 | SKIN- OR HAIR-CLEANSING COMPOSITION CONTAINING AQUEOUS GELLING AGENT, AND METHODS FOR PRODUCING AQUEOUS GELLING AGENT AND CLEANSING COMPOSITION | 2021-01-07 |
| 20210000721 | ORAL CARE COMPOSITIONS FOR PROMOTING GUM HEALTH | 2021-01-07 |
| 20210000722 | ORAL CARE COMPOSITIONS FOR PROMOTING GUM HEALTH | 2021-01-07 |
| 20210000723 | ORAL CARE COMPOSITIONS FOR PROMOTING GUM HEALTH | 2021-01-07 |
| 20210000724 | PERSONAL CARE CLEANING COMPOSITIONS | 2021-01-07 |
| 20210000725 | Oral Care Composition Comprising Rottlerin | 2021-01-07 |
| 20210000726 | COMPOSITION FOR ENHANCING SKIN ELASTICITY OR IMPROVING SKIN WRINKLES COMPRISING HEPTAHYDROXYFLAVAN AS AN EFFECTIVE INGREDIENT | 2021-01-07 |
| 20210000727 | DITHIAZOCANE COMPOUNDS FOR THE COSMETIC USE THEREOF | 2021-01-07 |
| 20210000728 | Formulations for Enhancing Skin Firmness, Density and Thickness | 2021-01-07 |
| 20210000729 | METHOD OF MANUFACTURING COMPOSITION MATERIAL FOR SKIN MOISTURIZING CONTAINING VEHICLE HAVING MULTI-LAYER GLOBULE | 2021-01-07 |
| 20210000730 | COMPOSITION COMPRISING OPTICAL CLEARING AGENT FOR IMPROVING OPTICAL CHARACTERISTIC OF SKIN | 2021-01-07 |
| 20210000731 | TOPICAL COMPOSITION | 2021-01-07 |
| 20210000732 | Oral Care Composition for Long-Lasting Peroxide Delivery | 2021-01-07 |
| 20210000733 | FIBROUS STRUCTURES CONTAINING CATIONIC SURFACTANTS AND SOLUBLE ACIDS | 2021-01-07 |
| 20210000734 | A COMPOSITION SUITABLE FOR HAIR CARE | 2021-01-07 |
| 20210000735 | COMPOSITION FOR THE PREVENTION AND TREATMENT OF SKIN DAMAGES CAUSED BY PHOTO-EXPOSURE | 2021-01-07 |
| 20210000736 | Lipofilling with ex-vivo expanded adipose tissue-derived stem cells for cosmetic breast filling or for facial filling and/or rejuvenation | 2021-01-07 |
| 20210000737 | NASAL COMPOSITION COMPRISING A MUCOADHESIVE POLYMER | 2021-01-07 |
| 20210000738 | AEROSOL FORMULATION FOR COPD | 2021-01-07 |
| 20210000739 | METHOD TO PREPARE PHARMACEUTICAL COMPOSITIONS | 2021-01-07 |
| 20210000740 | COMPOSITIONS FOR SMALL MOLECULE THERAPEUTIC AGENT COMPOUNDS | 2021-01-07 |
| 20210000741 | PHARMACEUTICAL COMPOSITIONS COMPRISING SILICA MICROSPHERES | 2021-01-07 |
| 20210000742 | INTRAVAGINAL DEVICE AND USES THEREOF | 2021-01-07 |
| 20210000743 | STABLE LIQUID PHARMACEUTICAL PREPARATION | 2021-01-07 |
| 20210000744 | DRUG DELIVERY FORMULATIONS | 2021-01-07 |
| 20210000745 | POLYMER PARTICLES FOR NEUTROPHIL INJURY | 2021-01-07 |
| 20210000746 | PHARMACEUTICAL COMPOSITION COMPRISING META ARSENITE AND METHOD OF MANUFACTURE | 2021-01-07 |
| 20210000750 | ENGINEERED NANOVESICLES AS CHECKPOINT BLOCKADE FOR CANCER IMMUNOTHERAPY | 2021-01-07 |
| 20210000751 | NANOPARTICLE CANCER THERAPY | 2021-01-07 |
| 20210000752 | METHODS OF TREATING CENTRAL NERVOUS SYSTEM DISORDERS VIA ADMINISTRATION OF NANOPARTICLES OF AN MTOR INHIBITOR AND AN ALBUMIN | 2021-01-07 |
| 20210000753 | HOMEOPATHIC THERAPEUTIC METHOD AND COMPOSITIONS | 2021-01-07 |
| 20210000754 | TRANSDERMAL PATCH PROVIDING IMPROVED PERMEABILITY AND COMPOSITION | 2021-01-07 |
| 20210000755 | TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF BUPRENORPHINE COMPRISING A SILICONE ACRYLIC HYBRID POLYMER | 2021-01-07 |
| 20210000756 | TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING A SILICONE ACRYLIC HYBRID POLYMER | 2021-01-07 |
| 20210000758 | TREATMENT OF OCULAR DISEASES WITH OPHTHALMIC TAPINAROF COMPOSITIONS | 2021-01-07 |
| 20210000759 | CANNABINOID AND MENTHOL COMPOSITIONS AND METHODS | 2021-01-07 |
| 20210000760 | ALCOHOL-BASED COMPOSITIONS AND USES THEREOF | 2021-01-07 |
| 20210000761 | TOPICAL CO-ENZYME Q10 FORMULATIONS AND TREATMENT OF PAIN, FATIGUE AND WOUNDS | 2021-01-07 |
| 20210000762 | PREVENTIVE OR THERAPEUTIC AGENT AND PHARMACEUTICAL COMPOSITION FOR INFLAMMATORY DISEASES OR BONE DISEASES | 2021-01-07 |
| 20210000763 | BUPROPION AS A MODULATOR OF DRUG ACTIVITY | 2021-01-07 |
| 20210000764 | BUPROPION AS A MODULATOR OF DRUG ACTIVITY | 2021-01-07 |
| 20210000765 | BUPROPION AS A MODULATOR OF DRUG ACTIVITY | 2021-01-07 |
| 20210000766 | SPHINGOSINE PATHWAY MODULATING COMPOUNDS FOR THE TREATMENT OF CANCERS | 2021-01-07 |
| 20210000767 | MUSCULAR ATROPHY-INDUCING AGENT USING HYPOMETABOLISM-INDUCING SUBSTANCE T1AM, AND USE THEREOF IN TREATING MUSCULAR HYPERTROPHY | 2021-01-07 |
| 20210000768 | BUPROPION AS A MODULATOR OF DRUG ACTIVITY | 2021-01-07 |
| 20210000770 | METHOD OF PROVIDING CELIPROLOL THERAPY TO A PATIENT | 2021-01-07 |
| 20210000771 | EPILEPSY TREATMENT AGENT | 2021-01-07 |
| 20210000772 | METHODS OF TREATING LIVER FIBROSIS BY ADMINISTERING 3-BROMOPYRUVATE | 2021-01-07 |
| 20210000773 | Treatment of intrahepatic cholestatic diseases | 2021-01-07 |
| 20210000774 | Treatment of intrahepatic cholestatic diseases | 2021-01-07 |
| 20210000775 | CONTROLLED-RELEASE TABLETS, METHOD OF MAKING, AND METHOD OF USE THEREOF | 2021-01-07 |
| 20210000776 | PHARMACEUTICAL SUSPENSIONS CONTAINING DRUG PARTICLES, DEVICES FOR THEIR ADMINISTRATION, AND METHODS OF THEIR USE | 2021-01-07 |
| 20210000777 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | 2021-01-07 |
| 20210000778 | THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING PROSTATE CANCER USING 6,8-BIS-BENZYLTHIO-OCTANOIC ACID | 2021-01-07 |
| 20210000779 | METHODS OF TREATING MIXED DYSLIPIDEMIA | 2021-01-07 |
| 20210000780 | COMPOSITIONS AND METHODS OF USE OF PHORBOL ESTERS IN THE TREATMENT OF NEOPLASMS | 2021-01-07 |
| 20210000781 | METHODS FOR TREATING UREA CYCLE DISORDERS | 2021-01-07 |
| 20210000782 | APPLICATION OF DROFENINE OR SALT THEREOF TO PREPARATION OF MEDICINE FOR TREATING PERIPHERAL NEURON AXONAL INJURY AND PERIPHERAL RELATED NEUROPATHY | 2021-01-07 |
| 20210000783 | USE OF EXTRACT OF VEGETATION WATERS FOR TREATING DAMAGE TO THE CARDIOVASCULAR SYSTEM | 2021-01-07 |
| 20210000784 | METHODS OF THERAPEUTIC MONITORING OF NITROGEN SCAVENGING DRUGS | 2021-01-07 |
| 20210000785 | KETONE CARBONYL-CONTAINING HYDROPHOBIC ANTITUMOR DRUG AND CONJUGATE THEREOF AS WELL AS NANO PREPARATION CONTAINING CONJUGATE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | 2021-01-07 |
| 20210000786 | Taxane Particles and Their Use | 2021-01-07 |
| 20210000787 | QUERCETIN-BASED COMPOSITION FOR TREATING RHINOSINUSITIS | 2021-01-07 |
| 20210000788 | NANOPARTICLE ISOFLAVONE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | 2021-01-07 |
| 20210000789 | DEFINED DOSE CANNABIS POD | 2021-01-07 |
| 20210000790 | ISOFLAVONOID COMPOUNDS AND METHODS FOR THE TREATMENT OF CANCER | 2021-01-07 |
| 20210000791 | WATER SOLUBLE COMPOSITIONS COMPRISING PURIFIED CANNABINOIDS | 2021-01-07 |
| 20210000792 | METHODS FOR REDUCING OR PREVENTING CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE II DIABETES MELLITUS | 2021-01-07 |
| 20210000793 | COMPOSITION FOR PREVENTING OR TREATING HAIR LOSS | 2021-01-07 |
| 20210000794 | Drug and Method of Treating or Preventing Renal Disease Using Drug | 2021-01-07 |
| 20210000795 | ERGOTHIONEINE COMPOSITIONS AND METHODS FOR MAINTAINING AND/OR INCREASING VITAMIN C LEVELS IN CELLS AND ORGANISMS | 2021-01-07 |
| 20210000796 | FORMULATION FOR USE IN THE TREATMENT OF UREMIC PRURITUS | 2021-01-07 |
| 20210000797 | MOLECULAR GENETIC APPROACH TO TREATMENT AND DIAGNOSIS OF ALCOHOL AND DRUG DEPENDENCE | 2021-01-07 |
| 20210000798 | 2,6-DIMETHOXY-4-(5-PHENYL-4-THIOPHENE-2-YL-1H-IMIDAZOL-2-YL)-PHENOL (DPTIP) A SMALL MOLECULE INHIBITOR OF NEUTRAL SPHINGOMYELINASE 2 (nSMase-2) FOR THE TREATMENT OF NEURODEGENERATIVE AND ONCOLOGIC DISEASES | 2021-01-07 |
| 20210000799 | CHEMICAL INHIBITORS OF MYCOBACTERIUM TUBERCULOSIS DOSRST SIGNALING AND PERSISTENCE | 2021-01-07 |
| 20210000800 | MAMMARY TUMOR VIRUS SUPPRESSION | 2021-01-07 |
| 20210000801 | COMPOSITION FOR PREVENTION AND TREATMENT OF HAIR GROWTH DISORDERS | 2021-01-07 |
| 20210000802 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING AIDS COMPRISING RHODANINE DERIVATIVE | 2021-01-07 |
| 20210000803 | TREATMENT OF UNIPOLAR DEPRESSIVE DISORDER | 2021-01-07 |
| 20210000804 | COMBINATION OF IBUDILAST AND RILUZOLE AND METHODS OF USING SAME | 2021-01-07 |
| 20210000805 | METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS | 2021-01-07 |
| 20210000806 | COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE AND FUSOBACTERIA-CAUSED OR RELATED DISEASES AND CONDITIONS | 2021-01-07 |
| 20210000807 | COMPOUNDS AND METHODS FOR USE IN THE TREATMENT OF MICROGLIA-MEDIATED DISORDERS | 2021-01-07 |
| 20210000808 | NICOTINAMIDE RIBOSIDE TREATMENTS OF DOMESTICATED MEAT ANIMALS | 2021-01-07 |
